Publications by authors named "P Celerier"

Claim this Profile
I
Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).
F Skowron, S Mouret, A Seigneurin, H Montaudié, E Maubec

Ann Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of adjuvant therapies in stage III/IV melanoma: Insights from the French RIC-MEL cohort.
M Vuillemey, T Goronflot, P Celerier, D Legoupil, L Misery

J Eur Acad Dermatol Venereol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns.
M Amini-Adle, J-P Arnault, F Aubin, N Beneton, G Bens

Ann Dermatol Venereol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study.
Brigitte Dréno, Jean-Michel Nguyen, Ewa Hainaut, Laurent Machet, Marie-Thérèse Leccia

Acta Derm Venereol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database.
Jean-Matthieu L'Orphelin, Sara Le Naour, Stephane Dalle, Emilie Varey, Alain Dupuy, Philippe Celerier

Eur J Dermatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis